Home › Funds › UBS Group AG › BMEA
UBS Group AG position in BMEA
BIOMEA FUSION INC · Health Care
Latest position (Q2 2026)444.73K sh
Reported value held$653.75K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 100 | $1.00K | New |
| Q4 2021 | 7.30K | $55.00K | Add |
| Q1 2022 | 355 | $1.00K | Reduce |
| Q2 2022 | 100 | $1.00K | Reduce |
| Q3 2022 | 4.08K | $40.00K | Add |
| Q4 2022 | 1.10K | $9.29K | Reduce |
| Q1 2023 | 186 | $5.77K | Reduce |
| Q2 2023 | 35.59K | $781.13K | Add |
| Q3 2023 | 55.80K | $767.81K | Add |
| Q4 2023 | 73.31K | $1.06M | Add |
| Q1 2024 | 264.20K | $3.95M | Add |
| Q2 2024 | 48.01K | $216.03K | Reduce |
| Q3 2024 | 34.30K | $346.46K | Reduce |
| Q4 2024 | 126.04K | $489.03K | Add |
| Q1 2025 | 236.88K | $504.55K | Add |
| Q2 2025 | 247.66K | $445.79K | Add |
| Q3 2025 | 94.53K | $190.95K | Reduce |
| Q4 2025 | 1.16M | $1.44M | Add |
| Q1 2026 | 515.55K | $788.80K | Reduce |
| Q2 2026 | 444.73K | $653.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMEA
- Fidelity Management & Research (FMR) 8.81M sh · $12.96M · Q2 2026
- Vanguard Group 2.97M sh · $3.68M · Q4 2025
- Marshall Wace 2.05M sh · $3.01M · Q2 2026
- Renaissance Technologies 1.46M sh · $2.14M · Q2 2026
- BlackRock Inc 715.45K sh · $1.05M · Q2 2026
- Geode Capital Management 708.85K sh · $1.04M · Q2 2026
- Two Sigma Investments 384.46K sh · $565.15K · Q2 2026
- Morgan Stanley 367.02K sh · $539.52K · Q2 2026
- Citadel Advisors 236.42K sh · $347.53K · Q2 2026
- Northern Trust Corp 128.53K sh · $188.93K · Q2 2026
- Goldman Sachs Group 93.76K sh · $137.82K · Q2 2026